Table 2.

Bisphosphonate Use in the Full Data Set

Parameter	Use of bisphosphonate, yes/assessed (% yes)	Age at initiation, median month (range)
Full data set (n = 127)
All bisphosphonates	63/114 (55.2)
Etidronate	42/63 (66.7)	1.6 (−3.1 to 342)
Pamidronate	29/63 (46)	0.8 (0.0–70.7)
Risedronate	9/63 (14.2)	2.6 (0.6–66.7)
Multiple agents	40/63 (63.5)
ENPP1 (n = 84)
All bisphosphonates	45/75 (60.0)
Etidronate	27/45 (60.0)	1.2 (−3.1 to 342.0)
Pamidronate	22/45 (48.9)	0.7 (0.0–70.7)
Risedronate	8/45 (17.8)	2.0 (0.6–66.7)
Multiple agents	29/45 (64.4)
ABCC6 (n = 19)
All bisphosphonates	13/19 (68.4)
Etidronate	13/13 (100.0)	5.5 (−1.6 to 62.5)
Pamidronate	5/13 (38.5)	2.0 (0.7–3.4)
Risedronate	0/13 (0.0)
Multiple agents	9/13 (69.2)